Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2013
Reporting Period: Third fiscal quarter ended September 30, 2013
This filing serves as a notification that the company issued a press release announcing its third-quarter 2013 results of operations. The detailed financial data is contained in the press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the filing text itself.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the announcement of the third-quarter results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing management's discussion of the third-quarter results but does not include the commentary text.
Legal Disclaimer: The information in this Current Report is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act. It shall not be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 4, 2013) for specific revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance trends in the attached press release.
- Check for any forward-looking statements or guidance updates included in the press release.
- Confirm the company's liquidity position and debt obligations as detailed in the full financial results.